Arch Dis Child Educ Pract Ed doi:10.1136/archdischild-2012-302876
  • Picket

Isoniazid prophylaxis started at 3–4 months of life does not prevent tuberculosis disease or infection in both HIV-infected and uninfected children

Setting: South Africa and Botswana

Patients: The study looked at infants who were born to HIV-infected women. To be included in the study, the infants had to be between 91 and 120 days of life, not infected with or exposed to a case of tuberculosis, without other chronic illness, or immunosuppressed from an infection other than HIV.

A total of 1351 children were included in the analysis and were split into two groups based on their HIV status after testing: HIV positive and HIV negative (table 1).

Intervention: The infants in both groups were randomly assigned to receive either isoniazid at a daily dose of 10–20 mg/kg or placebo. The study drug was initiated four days into randomisation, and continued for 96 weeks in total. All HIV-infected children continued to have access to …

Correspondence to Dr Mildred Adaku Iro, Department of Paediatrics, Queen Alexandra Hospital, Portsmouth PO6 3LY, UK; adakuiroh{at}

Register for free content

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of ADC Education & Practice.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article